Gujarat Terce Laboratories (BOM:524314) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524314 Gujarat Terce Laboratories Ltd BOM:524314
57 GF Score
Price ₹35.00
GF Value ₹44.92
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Gujarat Terce Laboratories Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Gujarat Terce Laboratories Valuation Rank Related Terms

BOM:524314
57GF Score
Gujarat Terce Laboratories Ltd BOM:524314
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gujarat Terce Laboratories (BOM:524314) Overvalued in 2026?

Based on GuruFocus' analysis, Gujarat Terce Laboratories stock appears to be undervalued. The current stock price of ₹35.00 is trading 22.1% below its estimated GF Value™ of ₹44.92. GuruFocus considers Gujarat Terce Laboratories to be Modestly Undervalued.

Key valuation signals for BOM:524314:

  • Valuation Rank:
  • GF Value™: ₹44.92 vs. price of ₹35.00 (22.1% below fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the BOM:524314 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gujarat Terce Laboratories Business Description

Address Near Shivalik High-Street, Unit No. D/801-802 and 1202,The First, Behind Keshavbaug Party Plot, Vastrapur, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an Indian company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, syrup, and injections. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, antifungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash, Aziter, and others.
57GF Score

Get the complete analysis for BOM:524314

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.00
Price
₹44.92
GF Value